A live audio webcast of the presentation will be available at http://www.acurapharm.com. A replay of the webcast will also be available for approximately 14 days on the same website.
About Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) (abuse deterrent) Technology and related product candidates.
The Acura Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4847
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc.
Peter A. Clemens, SVP Investor Relations & CFO
847-705-7709

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index